Thomas Weisel Downgrades Netflix (NFLX) to Market Weight
Thomas Weisel downgrades Netflix (Nasdaq: NFLX) from Overweight to Market Weight.
Kosan Biosciences Incorporated, a cancer therapeutics company, focuses on developing various classes of anticancer agents through clinical development.
Related Categories
DowngradesStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
